By Janine Savage, RN, CHC
VP, Product Management, Analytics & Business Intelligence
Since the CMS Final Rule announcing the Patient-Driven Payment Model (PDPM) was released, there has been much speculation among SNF providers and industry experts about what compliance will look like under the new reimbursement system. Under RUG-IV, compliance primarily depends on one key metric: medical necessity for therapy services. Due to the high percentage of billed days in therapy groups, Medicare program integrity was laser-focused on documentation and billing for therapy services, to ensure that the therapy furnished to the SNF beneficiary was reasonable and necessary.
But PDPM is very different than RUG-IV. PDPM payment is based upon patient characteristics and diagnoses as reported on the Minimum Data Set (MDS), not the amount of therapy delivered. MDS coding determines payment as MDS items drive the calculation of the five case-mix components. For proper reimbursement, MDS coding must be accurate. [Learn more about the Minimum Data Set (MDS) ]
Compliance Changes Under PDPM
At this year’s HCCA annual Compliance Institute, held in Boston in April, at least seven educational sessions addressed compliance under PDPM, with several national industry experts weighing in. ICD-10 diagnosis coding and MDS item coding accuracy were two compliance risk areas consistently projected as becoming prime targets for “government enforcers.” And at the Quality Reporting Program Provider Training on May 8, 2019, CMS fired an unmistakable warning shot across the bow:
“Given the more holistic style of care emphasized under PDPM, program integrity and data monitoring efforts will also be more comprehensive and broad. For program integrity, we expect provider risk will be more easily mitigated to the extent that reviews focus on more clearly defined aspects of payment, such as documentation supporting patient diagnoses and assessment coding.”1
Clearly medical necessity reviews under PDPM will concentrate on the provider’s medical record documentation to support MDS coding. But if you think that therapy doesn’t matter anymore, think again. CMS will also monitor therapy service provision under PDPM as compared to RUG-IV, and “significant changes in the amount of therapy provided to SNF patients/residents under PDPM, as compared to RUG – IV, or the manner in which it is delivered, may trigger additional program reviews and potential policy changes.”2
What’s A Provider To Do?
First, beware of PDPM “solutions” that are designed to help you get the highest payment, no matter what. Tools like “diagnosis optimizers” should be used with extreme caution. In the short term, they may help get you get a higher payment rate – but recoupment of overpayments may follow if medical necessity is not supported by medical record documentation. In the worst-case scenario, they could help the government show intent to defraud in a False Claims action, leading to fines and even a Corporate Integrity Agreement.
An effective and compliant PDPM solution ensures you get the highest payment your documentation supports, so you can keep it. PointRight’s actionable analytics insights identify risk areas to form the foundation of a comprehensive, data-driven PDPM compliance program. Resident MDS-level analysis identifies potential issues before the assessment data even creates the Medicare claim, so they can be corrected before you bill. Ongoing insight into PDPM compliance-related outcomes at the facility level highlights compliance risks so they can be addressed in your compliance monitoring and auditing plan.
The transition to PDPM is going to have many unavoidable challenges, but compliance doesn’t need to be one of them! Educate yourself, listen to industry compliance experts, and use your trusted partners to help you successfully navigate these choppy waters.
About the Author

Janine Savage, RN, CHC
VP, Product Management, Analytics & Business Intelligence
Janine provides leadership and direction to create impactful, high-value analytics solutions throughout the Net Health product portfolio. By leveraging her clinical and business operations expertise and working closely with key stakeholders on the design, development, and implementation of analytics, she helps clients achieve their strategic goals and succeed in value-based care.